Printer Friendly

Browse Pharmaceutical industry topic

Intellectual property subtopic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Biogen, Teva reach settlement agreement related to Vumerity patents. Oct 11, 2021 171
The Bristol-Myers Squibb-Pfizer Alliance issues statement on US Court of Appeals for the Federal Circuit decision upholding Eliquis(R) Patents. Sep 6, 2021 182
The Bristol-Myers Squibb-Pfizer Alliance issues statement on US Court of Appeals for the Federal Circuit decision upholding Eliquis(R) Patents. Sep 6, 2021 183
SpringsWorks Therapeutics announces new patent issuance to mirdametinib. Jul 20, 2021 160
WHO pleads for Intellectual Property waivers to enable Africa manufacture local vaccines to tackle COVID pandemics. May 27, 2021 569
Bolivia signs a deal for 15 million doses of J&J's COVID-19 vaccine requiring WTO patent waiver. May 12, 2021 315
Bolivia signs a deal for 15 million doses of J&J's COVID-19 vaccine requiring WTO patent waiver. May 12, 2021 316
UK called to support proposal to waive patent protection for COVID-19 vaccines. May 11, 2021 266
UK called to support proposal to waive patent protection for COVID-19 vaccines. May 11, 2021 266
Pope joins Meghan Markle and Harry in calling for 'universal access' for Covid vaccines; Pope Francis backed "universal access to the vaccine and the temporary suspension of intellectual property rights" as coronavirus cases and deaths continue to surge in India. By, Emma Grimshaw May 9, 2021 576
Will US backing of waiver on vaccine patents boost supply in Korea? May 7, 2021 637
Waiver on vaccine patent protections. May 7, 2021 469
US-backed vaccine patent waiver: pros and cons explained. May 7, 2021 825
Moderna, Pfizer drop after US backs proposal to lift patent protection for COVID-19 vaccines to boost supply. May 7, 2021 184
Moderna, Pfizer drop after US backs proposal to lift patent protection for COVID-19 vaccines to boost supply. May 7, 2021 184
US backs plan to waive Covid-19 vaccine patents. May 7, 2021 865
U.S. Backs Waiving Intellectual Property Rules On Covid Jabs. May 6, 2021 1129
Covid vaccines could be cheaper for poor nations with patent change in pipeline; The US and EU could back waiving patent rights held by pharmaceutical giants, making it cheaper to produce jabs -but the UK has opposed the plans and pharma firms are worried. By, Ben Glaze May 6, 2021 598
Issues As Rites, NBC, Again, Spark Trademark Row In Energy Drinks Market. Apr 5, 2021 546
Vectura unveils special dividend after GlaxoSmithKline pays millions for litigation. Mar 19, 2021 438
Viatris symbicort generic in tentative US backing amid patent dispute. Mar 9, 2021 227
AstraZeneca reports US court decision favouring Symbicort patents. Mar 3, 2021 294
Genixus names new CCO and new executive vice president, global head of Intellectual Property. Mar 3, 2021 159
Genixus names new CCO and new executive vice president, global head of Intellectual Property. Mar 3, 2021 158
AstraZeneca reports US court decision favouring Symbicort patents. Mar 3, 2021 293
Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress. Hickey, Kevin J.; Richards, Kevin T.; Ward, Erin H. Report Mar 1, 2021 24220
Pfizer Wins US Patent Term Extension for Ibrance Until March 2027. Feb 5, 2021 309
Shield Therapeutics says TEVA has withdrawn patent challenge. Oct 20, 2020 271
i-Nexus surges as chairman stumps up to keep the lights on. Oct 20, 2020 3010
Patent fight success for drugs firm. Oct 20, 2020 160
Commoning Molecules: Decolonising Biological Patents by Gender Hacking Protocols. Fragnito, Maddalena Report Oct 1, 2020 7703
The Evergreening Myth: Claims that drug innovators extend their patents obscure a radical policymaking goal. Lietzan, Erika Sep 22, 2020 4894
Pfizer's Upjohn Files Patent Infringement Suit Over Lyrica In Japan. Aug 17, 2020 200
Set aside patents at this time of great need; VIEWPOINTS Write to: Viewpoints, M.E.N, Mitchell Henry House, Hollinwood Avenue, Oldham, OL9 8EF Or email: viewpoints@men-news.co.uk. Jul 24, 2020 915
More Data On Cell Therapy Program For Spinal Cord Injury. Jul 13, 2020 545
Amgen announces appeals court affirms validity of Enbrel patents. Jul 1, 2020 165
Regeneron's VelocImmune Patents Revoked In UK; Denies US Allegations. Jun 25, 2020 725
Morgan Stanley sees Eliquis patent being upheld, ruling being 'imminent'. Jun 22, 2020 172
Mylan Wins US Court Decision In Tecfidera Patent Dispute With Biogen. Jun 19, 2020 282
Provectus issues patent from IPO for combination of PV-10, therapy. Jun 9, 2020 385
Indivior Considers Appeal Options For Suboxone Patent Ruling. Jun 3, 2020 211
Mylan Cheers US Patent Board Shutting Down Sanofi Over Lantus Patents. Jun 1, 2020 461
PTAB rules in favor of Mylan, invalidating Sanofi Lantus SoloSTAR patents. May 29, 2020 193
AGREEMENT EXPANDS GENPREX ONCOLOGY FRANCHISE. May 27, 2020 579
Amgen: KYPROLIS patents upheld against generic manufacturer. May 5, 2020 200
Matinas BioPharma weighs in on Amarin drug case, pauses clinical enrollment amid coronavirus. Apr 1, 2020 663
Hikma receives favourable ruling in generic Vascepa patent suit from US Court. Mar 31, 2020 196
Hikma receives favourable ruling in generic Vascepa patent suit from US Court. Mar 31, 2020 192
Matinas says Vascepa patent ruling has no impact on validity of MAT9001 patents. Mar 31, 2020 466
Batten down the Hatch[es]! Restoring the Patent System's Role within the Pharmaceutical Industry. Screnci, Rocco Mar 22, 2020 12686
Mylan wins in district court dispute against Sanofi's Lantus patent. Mar 10, 2020 318
RegeneRx Biopharmaceuticals receives new patent from Canadian Patent Office to Henry Ford Health System. Feb 14, 2020 174
RegeneRx Biopharmaceuticals receives new patent from Canadian Patent Office to Henry Ford Health System. Feb 14, 2020 170
Medivir's MIV-818 patent applications receive notices of allowance in EU and Japan. Jan 31, 2020 216
Medivir's MIV-818 patent applications receive notices of allowance in EU and Japan. Jan 31, 2020 217
Medivir's MIV-818 patent applications receive notices of allowance in EU and Japan. Jan 31, 2020 212
Frontier IP's Fieldwork Robotics raises [pounds]298,000 in first funding round. Jan 15, 2020 306
Vectura expects sales and earnings "at least" in line with expectations. Financial report Jan 14, 2020 338
65 Biggest Movers From Yesterday. Lisa Levin Jan 3, 2020 1461
Naked Price and Pharmaceutical Trade Secret Overreach. Feldman, Robin; Graves, Charles Tait Jan 1, 2020 31042
WHAT IS THE TRADE-OFF: ARE NEW TRADE DEALS WORTH THE CHANGES TO PHARMACEUTICAL PATENTS? Carter, Kaitlyn Jan 1, 2020 5741
US Patent Issued for Method of Generating Induced Pluripotent Stem Cells. Dec 12, 2019 669
Can-Fite Obtains Patent For Treatment Of Osteoarthritis In Mammals. Nina Zdinjak Nov 11, 2019 370
Elucid mHealth awarded US patents for its groundbreaking patient medication dherence system. Oct 31, 2019 689
Hemogenyx Inks USD75,000 Research Deal With Undisclosed Global Firm. Oct 23, 2019 338
The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug. Shanthi Rexaline Oct 9, 2019 987
Bausch Health Companies Inc. (NYSE:BHC) - Bausch Health Files Lawsuit Against Sandoz For Infringement Of Patents Protecting XIFAXAN[R] 550 mg Tablets -- 1/10/2019. Oct 7, 2019 224
Novartis Loses Patent Case; Gets Positive Migraine Treatment Results. Sep 9, 2019 208
AstraZeneca signs IP agreement with Theragnostics. Sep 5, 2019 103
Sanofi - U.S. District Court invalidates Amgen patent claims targeting PCSK9 - 28/8/2019. Sep 5, 2019 203
Pfizer to combine off-patent business. Aug 31, 2019 229
Drugs and rights. Aug 30, 2019 849
US Court Invalidates Amgen Patent, Rules In Favour Of Sanofi. Aug 29, 2019 258
US judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight. Aug 29, 2019 341
Regeneron says U.S. court invalidates Amgen patent claims targeting PCSK9. Aug 28, 2019 154
Mallinckrodt falls 13% after appeals court rejects patent suit against Praxair. Aug 27, 2019 136
Eli Lilly and Company UK (NYSE: LLY) - U.S. Court of Appeals Rules in Favor of Lilly in Alimta Alternate Salt Form Patent Lawsuit -- 9/8/2019. Aug 20, 2019 438
Eli Lilly and Company UK (NYSE: LLY) - U.S. Court of Appeals Rules in Favor of Lilly in Alimta Alternate Salt Form Patent Lawsuit -- 9/8/2019. Aug 14, 2019 438
Amgen (NASDAQ: AMGN) - Amgen Wins Patent Case On Enbrel[R] (etanercept) -- 9/8/2019. Aug 13, 2019 251
Amgen (NASDAQ:AMGN) - Amgen Wins Patent Case On Enbrel[R] (etanercept) -- 9/8/2019. Aug 13, 2019 236
Eli Lilly & Company (NYSE: LLY) - U.S. Court of Appeals Rules in Favor of Lilly in Alimta Alternate Salt Form Patent Lawsuit -- 9/8/2019. Aug 13, 2019 438
Pfizer combines its off-patent drug business with Mylan. Aug 12, 2019 574
Study Finds Voter Opposition to Patent Settlement Legislation. Aug 12, 2019 564
Eli Lilly announces court ruling in favor of its Alimta patent. Aug 9, 2019 133
Novartis' Sandoz to appeal ruling in biosimilar Erelzi U.S. patent case. Aug 9, 2019 193
Novartis 'pleased' with decision in Sandoz patent case. Aug 9, 2019 221
Amgen 'pleased' with decision in Sandoz patent case. Aug 9, 2019 221
CARMA LABS PATENTS HYDRATING LIP BALM. Aug 1, 2019 796
Bausch Health resolved Apriso intellectual property litigation with Teva. Aug 1, 2019 147
Pfizer agrees to spin off and merge off-patent drugs unit with Mylan. Jul 30, 2019 194
Pfizer to spinoff, merge off-patent drugs unit with Mylan. Jul 29, 2019 760
Pfizer near deal to merge off-patent business with Mylan, WSJ reports. Jul 28, 2019 121
Amarin prepared to defend patents against Epanova launch, says H.C. Wainwright. Jul 26, 2019 142
Bausch Health Companies Inc. (NYSE:BHC) - Court Upholds The Validity And Determined Actavis' Infringement Of Patent Protecting RELISTOR[R] Tablets -- 17/7/2019. Jul 22, 2019 146
Alkermes, Janssen accuse Luye Pharma of patent infringement. Jul 18, 2019 142
Provectus receives notice of allowance for cancer combination therapy patent. Jul 15, 2019 182
FINDING A FOREST THROUGH THE TREES: GEORGIA-PACIFIC AS GUIDANCE FOR ARBITRATION OF INTERNATIONAL COMPULSORY LICENSING DISPUTES. McKenzie, Karen Jun 22, 2019 10637
Teva Appeals Shield Therapeutics European Drug Patent Win. Jun 3, 2019 186
Enzo Biochem Issued United States Patent for Treatment of Liver Cancer Using Ozanimod. Disease/Disorder overview May 16, 2019 291
CytRx Corporation granted US patent for aldoxorubicin for brain cancer. May 9, 2019 126
CytRx Corporation granted US patent for aldoxorubicin for brain cancer. May 9, 2019 127
Eli Lilly says court rules in company's favor over Alimta vitamin regimen patent. Apr 26, 2019 284
Astellas Pharma Inc. - Astellas Announces Key Leadership Promotions and New Hire in Legal, IP and Immuno-Oncology -- 28/2/2019. Apr 16, 2019 605
Insmed wins additional US patent for ARIKAYCE (amikacin liposome inhalation suspension) for treating MAC lung disease. Apr 10, 2019 292
Insmed wins additional US patent for ARIKAYCE (amikacin liposome inhalation suspension) for treating MAC lung disease. Apr 10, 2019 288
European Patent For Brainstorm's Treatment Of CNS Diseases. Disease/Disorder overview Apr 1, 2019 111
European Patent For Brainstorm's Treatment Of CNS Diseases. Disease/Disorder overview Apr 1, 2019 111
STRANGE BEDFELLOWS: NATIVE AMERICAN TRIBES, BIG PHARMA, AND THE LEGITIMACY OF THEIR ALLIANCE. Kennedy, Daniel C. Apr 1, 2019 14594
Drug Pricing and Intellectual Property Law: A Legal Overview for the 116th Congress. Hickey, Kevin J.; Ward, Erin H.; Shen, Wen W. Apr 1, 2019 30948
Progenics asserts ownership of PMSA-617 intellectual property. Mar 14, 2019 246
Statutory Interpretation Leahy-Smith America Invents Act. Feb 26, 2019 278
Delaware jury upholds Amgen's patents on Repatha. Feb 25, 2019 194
Regeneron reports decisions from the US and EU Patent Office to invalidate Immunex patents claiming antibodies to the IL-4 receptor. Feb 18, 2019 240
Regeneron reports decisions from the US and EU Patent Office to invalidate Immunex patents claiming antibodies to the IL-4 receptor. Feb 18, 2019 236
Pre-patent sales curbed: SCOTUS decision clears up rules on secret commercial deals. Christon, Rebecca C.; Sullivan, Todd A. Feb 15, 2019 689
Regeneron says EPO revoes Immunex's European patent No. 2,990,420. Feb 15, 2019 173
Regeneron says EPO revokes Immunex's European patent No. 2,990,420. Feb 15, 2019 173
Cerecor announces CERC-301 granted U.S. patent. Feb 15, 2019 184
Sanofi, Regeneron win IPR challenge to Amgen IL-4 patent. Feb 14, 2019 130
Can-Fite Receives Notice of Allowance from US Patent and Trademark Office for Osteoarthritis Drug. Feb 4, 2019 493
Genmab's announces patents asserted by MorphoSys against DARZALEX in the US declared invalid by summary judgment. Jan 28, 2019 240
Genmab's announces patents asserted by MorphoSys against DARZALEX in the US declared invalid by summary judgment. Jan 28, 2019 241
MorphoSys announces asserted claims of three patents ruled invalid. Jan 28, 2019 155
Genmab says patents asserted against Darzalex in U.S. declared invalid. Jan 28, 2019 178
MorphoSys weakness on patent ruling a buying opportunity, says Piper Jaffray. Jan 28, 2019 111
Teva announces resolution of litigation with Amgen over Teva's generic cinacalet HCl product. Jan 3, 2019 225
Teva announces resolution of litigation with Amgen over Teva's generic cinacalet HCl product. Jan 3, 2019 229
Teva and Amgen Resolve Ongoing Dispute Over Teva's Generic Cinacalet HCl Product. Jan 3, 2019 358
A MATHEMATICAL SOLUTION TO THE SINE OF MADNESS THAT IS PHARMACEUTICAL COMPULSORY LICENSING UNDER THE TRIPS AGREEMENT AND THE DOHA DECLARATION. Sperbeck, Ashley E. Jan 1, 2019 13138
Accessing Continuous Glucose Monitoring (CGM) Sensors in France and the US: A Comparative Case Study of Abbott's Freestyle Libre (FSL) System. Perrier, Lucie Report Jan 1, 2019 10381
Beyond Heart Health The Systemic Benefits of CoQ10. Thacker, Jake Report Jan 1, 2019 3235
Mylan: Sanofi patents on Lantus invalidated by U.S. PTAB via IPR. Dec 13, 2018 142
Confo Therapeutics Appoints Landolt as its Chief Counsel Legal and Intellectual Property. Dec 7, 2018 336
THE UNEASY CASE FOR PATENT LAW. Sachs, Rachel E. Dec 1, 2018 22778
Bavarian Nordic announces first patent dosed and initiation of clinical trial evaluating the combination therapy of CV301 and Durvalumab in metastatic colorectal and pancreatic cancers. Nov 5, 2018 421
Bavarian Nordic announces first patent dosed and initiation of clinical trial evaluating the combination therapy of CV301 and Durvalumab in metastatic colorectal and pancreatic cancers. Nov 5, 2018 417
Morgan Stanley says ruling on J&J's Zytiga patent not a surprise. Oct 29, 2018 114
Johnson & Johnson says court invalidates all claims on Zytiga patent. Oct 26, 2018 205
Mesoblast expands partnership with JCR Pharma in Japan for wound healing. Oct 24, 2018 151
Judge denies Teva's motion to dismiss Corcept's patent infringement claims. Oct 24, 2018 154
Velicept Therapeutics Raises an Additional USD 15m in series B Round, Initiates Phase 2b Study, Receives Issuance of US Patent. Oct 17, 2018 485
AbbVie announces Humira patent dispute resolution, terms not stated. Oct 11, 2018 157
Novartis division Sandoz, AbbVie resolve IP related litigation for Humira. Oct 11, 2018 181
Novartis division Sandoz, AbbVie resolve IP related litigation for Hyrimoz. Oct 11, 2018 175
Fly Intel: Pre-market Movers. Oct 10, 2018 177
The Complexity of Pharmaceutical Prices: An Economic Analysis. Blackstone, Erwin A.; Fuhr, Joseph P., Jr. Report Oct 1, 2018 8930
Acorda patent invalidity appeal for Ampyra denied by court. Sep 10, 2018 115
Acantha Wins $8.2 Million Patent Infringement Verdict Against DePuy Synthes. Sep 1, 2018 349
DURECT wins USD5m milestone payment from Indivior. Aug 31, 2018 189
DURECT wins USD5m milestone payment from Indivior. Aug 31, 2018 185
Assertio Therapeutics reaches patent infringement settlement with Purdue Pharma. Aug 30, 2018 199
Assertio Therapeutics reaches patent infringement settlement with Purdue Pharma. Aug 30, 2018 195
Assertio Therapeutics, Purdue Pharma settle patent infringement suit. Aug 28, 2018 106
DURECT awarded US FDA approval for PERSERIS (risperidone) to treat schizophrenia. Jul 31, 2018 198
Australia, China Grant Can-Fite Patents for Erectile Dysfunction Drug. Jul 24, 2018 176
PTAB decision on Gilenya positive for Celgene, says Piper Jaffray. Jul 12, 2018 160
Generex Biotechnology Corporation submits patent for new diagnostic point-of-care platform, the Express II. Jul 3, 2018 280
Generex Biotechnology Corporation submits patent for new diagnostic point-of-care platform, the Express II. Jul 3, 2018 276
Patent Infringement: Defensive Strategies for IP Violators. Fitzpatrick, William M.; Dilullo, Samuel A. Jul 1, 2018 15555
Notice Of Allowance For Japanese Patent For Stem Cell Treatment. Jun 25, 2018 129
Notice Of Allowance For Japanese Patent For Stem Cell Treatment. Jun 25, 2018 129
Japanese patent approved for VistaGen Therapeutics' stem cell technology. Jun 11, 2018 208
Japanese patent approved for VistaGen Therapeutics' stem cell technology. Jun 11, 2018 204
Osteoarthritis Treatment Using Stem Cell-Derived Chondrocytes. May 28, 2018 258
Osteoarthritis Treatment Using Stem Cell-Derived Chondrocytes. May 28, 2018 258
New Jersey court grants motion for partial summary judgment in RELISTOR patent. May 2, 2018 167
Causation in Reverse Payment Antitrust Claims. Soter, Kevin B. Apr 1, 2018 23661
Chugai receives favourable ruling in patent infringement lawsuit. Mar 28, 2018 177
Chugai receives favourable ruling in patent infringement lawsuit. Mar 28, 2018 173
Xenon Pharmaceuticals confirms closing of transaction with Teva. Mar 28, 2018 354
Corcept files lawsuit against Teva for infringement of Korlym patents. Mar 15, 2018 181
GlaxoSmithKline, Pfizer venture files patent infringement litigation against Gilead. Feb 8, 2018 138
Johnson & Johnson Remicade patent loss upheld on appeal. Jan 23, 2018 107
USPTO Rules in Favour of Argentum Pharmaceuticals in Invalidation Trial against Final Patent Protecting Janssen's Zytiga. Jan 23, 2018 208
US Patent & Trademark Office invalidates Johnson & Johnson's Zytiga patent. Jan 19, 2018 181
US Patent & Trademark Office invalidates Johnson & Johnson's Zytiga patent. Jan 19, 2018 177
Eisai: Patent Infringement Litigation for Antiemetic Agent ALOXI in the United States. Jan 18, 2018 749
India fast emerging as inventors' hub for drugs patent. Dec 24, 2017 662
Methods For Producing Blood Cells, Platelets, Marrow Stem Cells. Dec 11, 2017 144
Methods For Producing Blood Cells, Platelets, Marrow Stem Cells. Dec 11, 2017 144
Teva Prevails in Patent Case for Generic of Uceris. Nov 20, 2017 237
Alexion Receives New Japanese Patent for Soliris Extending Patent Protection Into 2027. Nov 6, 2017 352
Xenetic Grants Baxalta Right to Sublicense PolyXen Technology. Nov 3, 2017 185
Drug Companies Transfer Patents to Native American Tribes. Oct 31, 2017 537
Sanofi files suit in US to defend patent rights on Lantus and Lantus SoloStar. Oct 25, 2017 163
Sanofi files suit in US to defend patent rights on Lantus and Lantus SoloStar. Oct 25, 2017 159
Imprimis Launches Surface Pharmaceuticals Subsidiary. Oct 25, 2017 520
Senator Seeks to Close Tribal Patent Loophole. Brief article Oct 12, 2017 189
DURECT enters into USD17.5m patent purchase agreement with Indivior PLC. Oct 2, 2017 187
DURECT enters into USD17.5m patent purchase agreement with Indivior PLC. Oct 2, 2017 183
Down to a Science (and Technology): Tribe's Patent Assignment Deals Extend to High-Tech Patents. Hickey, Kevin J. Oct 1, 2017 765
Expiring patents point to better days ahead. Sep 25, 2017 359
DATA EXCLUSIVITY FOR PHARMACEUTICALS IN FREE TRADE AGREEMENTS: MODELS IN SELECTED UNITED STATES FREE TRADE AGREEMENTS. Armouti, Wael; Nsour, Mohammad Sep 22, 2017 11742
Patent Insight into Knee Replacement Prosthetics: Established leaders are primarily focused on traditional solutions while newer firms look to customization. Wen, Justin Sep 1, 2017 2310
Patentable Subject Matter Reform. Thomas, John R. Report Sep 1, 2017 9158
Pfizer granted patent on pneumonia vaccine, blow to aid group. Aug 23, 2017 583
India grants Pfizer patent for pneumonia vaccine. Aug 22, 2017 204
India grants Pfizer patent for pneumonia vaccine. Aug 22, 2017 200
USPTO Issues Three Patents to Alexion for Soliris (eculizumab). Aug 16, 2017 276
European Patent Office to Issue RegeneRx Patent for Peripheral Neuropathy Treatment. Aug 16, 2017 292
Onxeo announces divestment of products Sitavig and Loramyc to Vectans Pharma for EUR4.0m upfront payment. Aug 1, 2017 326
Bristol-Myers Squibb partners with Medicines Patent Pool to extend atazanavir licence for PLHIV in 122 developing countries. Jul 26, 2017 224
US FDA grants tentative approval for LUSDUNA Nexvue. Jul 24, 2017 142
US FDA grants tentative approval for LUSDUNA Nexvue. Jul 24, 2017 138
Intec Pharma awarded patent for Accordion Pill Carbidopa / Levodopa in Hong Kong. Jul 20, 2017 208
USPTO Issues Notice of Allowance to Biohaven on Patent Application for Glutamate Modulating Prodrugs. Jul 14, 2017 253
Biohaven awarded US Notice Of Allowance for patent for glutamate modulating prodrugs. Jul 13, 2017 204
Biohaven awarded US Notice Of Allowance for patent for glutamate modulating prodrugs. Jul 13, 2017 200
UK Supreme Court Determines Alimta Vitamin Regimen Patents Infringe on Eli Lilly. Jul 10, 2017 218
Citius' patent application for enhanced stability covering Mino-Lok published by the US Patent Office. Jun 20, 2017 221
M Pharmaceutical reports successful US FDA Pre-IND Meeting results for obesity management drug, C-103. May 31, 2017 179
Zipit Wireless gets patent for remote device management technology. May 16, 2017 217
Zipit Wireless gets patent for remote device management technology. May 16, 2017 204
Zipit Wireless gets patent for remote device management technology. May 16, 2017 217
Novartis loses Gilenya patent case. May 15, 2017 323
Novartis receives non-exclusive license from Celyad for TCR-deficient CAR-T cells patents. May 4, 2017 232
Novartis receives non-exclusive license from Celyad for TCR-deficient CAR-T cells patents. May 4, 2017 228
Bluebird Bio to License Lentiviral Vector Patent Rights to Novartis. May 3, 2017 306
European Patent for major depressive disorder treatment. Apr 3, 2017 140
European patent for major depressive disorder treatment. Apr 3, 2017 140
Product hopping. Carrier, Michael A. Essay Apr 1, 2017 6163
Coloring Consideration: Defining illegal payments in alleged "reverse payment" settlements between brand and generic drug makers post-Actavis. Barker, Michael Mar 22, 2017 15893
Achillion announces factor D inhibitors patent plus additional patent applications under review by the USPTO. Mar 22, 2017 261
Achillion announces factor D inhibitors patent plus additional patent applications under review by the USPTO. Mar 22, 2017 257
ANALYSIS OF THE PROPOSED TPP-RELATED PATENT LINKAGE SYSTEM IN TAIWAN. Chen, Ping-Hsun Mar 22, 2017 10432
Patents set to expire on 22 big meds. Feb 27, 2017 390
Insmed announces extension for long-term intellectual property protection for ARIKAYCE in the US. Feb 15, 2017 215
Insmed announces extension for long-term intellectual property protection for ARIKAYCE in the US. Feb 15, 2017 211
European Patent Office Upholds Decision Finding Bristol-Myers Squibb's Sprycel Patent Invalid. Feb 2, 2017 244
AstraZeneca sales fall following loss of cholesterol treatment patent protection. Feb 2, 2017 249
AstraZeneca sales fall following loss of cholesterol treatment patent protection. Feb 2, 2017 245
The US Court of Appeals rules in favour of Cumberland Pharmaceuticals' Acetadote patent case. Feb 1, 2017 212
The US Court of Appeals rules in favour of Cumberland Pharmaceuticals' Acetadote patent case. Feb 1, 2017 208
Teva to appeal Copaxone patent ruling. Jan 31, 2017 214
Teva to appeal Copaxone patent ruling. Jan 31, 2017 210
Delhi high court allows Ajanta Pharma to export drug in which Bayer has patent. Jan 30, 2017 279
Delhi high court allows Ajanta Pharma to export drug in which Bayer has patent. Jan 30, 2017 275
Jury Orders Gilead To Pay $2.54B In Royalties To Merck. Dec 16, 2016 338
The Little Blue Pill: A Look at Nonconventional Trademarks for Pharmaceuticals in the UAE. Dec 4, 2016 793
Mylan signs contract with Medicines Patent Pool. Nov 30, 2016 199
Mylan signs contract with Medicines Patent Pool. Nov 30, 2016 195
Mylan & Medicines Patent Pool alliance to increase access to Hepatitis C treatment in developing countries. Nov 29, 2016 236
Mylan & Medicines Patent Pool alliance to increase access to Hepatitis C treatment in developing countries. Nov 29, 2016 232
Cara, Pernix chronic pain drugs move forward. Sep 26, 2016 659
Merck introduces gene editing technology that can modify CHO cell lines. Sep 13, 2016 117
Merck introduces gene editing technology that can modify CHO cell lines. Sep 13, 2016 113
Perrigo wins tentative US FDA approval for generic Suprep Oral Solution; Confirms patent challenge for generic Mirvaso Gel. Aug 24, 2016 190
Perrigo wins tentative US FDA approval for generic Suprep Oral Solution; Confirms patent challenge for generic Mirvaso Gel. Aug 24, 2016 194
Arbutus awarded new US patent for LNP delivery technology for nucleic acids including mRNA. Aug 9, 2016 185
Arbutus awarded new US patent for LNP delivery technology for nucleic acids including mRNA. Aug 9, 2016 181
New Report Available: Puerto Rico Pharmaceuticals & Healthcare Report Q3 2016. Jul 3, 2016 498
March 31--multinational pharma giant GSK announces an intellectual property policy intended to improve access to innovative drugs and treatments for developing nations. Brief article Jul 1, 2016 179
Supernus awarded seventh US patent protecting its antiepileptic drug Oxtellar XR. Jun 23, 2016 173
Test Data Protection: Different Approaches and Implementation in Pharmaceuticals. Armouti, Wael; Nsour, Mohammad F.A. Jun 22, 2016 10571
ICENI PHARMACEUTICALS LAUNCHES AS NEW COMPANY. Jun 1, 2016 628
Icagen Granted US Patent for XRpro X-Ray Fluorescence Technology in Diagnostic, Discovery Applications. May 17, 2016 304
Court cases involving patent disputes on the rise. May 16, 2016 372
J&J patents sunscreen with UV radiation-absorbing polymer. Apr 1, 2016 104
A fair return approach to pharmaceutical compulsory licensing. Nuno, Maura Mar 22, 2016 7932
Study of intellectual property laws in Iranian pharmacology and drug industries. Babaee, Mahboubeh; Ebadi, Abdol Ghaffar Report Mar 1, 2016 2650
Court nixes patents for OxyContin. Feb 22, 2016 432
Suppliers brace for hit from patent expirations. Jan 4, 2016 345
RODES partners with Ligand for three Captisol-enabled (CE) programmes. Dec 9, 2015 229
RODES partners with Ligand for three Captisol-enabled (CE) programmes. Dec 9, 2015 225
BPCIA LITIGATION. Dec 7, 2015 1072
BPCIA LITIGATION. Dec 7, 2015 1113
La Jolla Pharmaceutical Company awarded Notice of Allowance for US patent LJPC-501 for the potential treatment of catecholamine-resistant hypotension. Dec 1, 2015 235
La Jolla Pharmaceutical Company awarded Notice of Allowance for US patent LJPC-501 for the potential treatment of catecholamine-resistant hypotension. Dec 1, 2015 231
Facebook debate: Pharmaceutical patents. Nov 28, 2015 490
Successful Ruling in Patent Infringement Litigation for Antiemetic Agent Aloxi in the United States. Nov 17, 2015 959
Novogen's patent for Cantrixil and Trilexium under SBP discovery programme accepted in Australia. Nov 12, 2015 225
Novogen's patent for Cantrixil and Trilexium under SBP discovery programme accepted in Australia. Nov 12, 2015 221
A fight worth watching: Genetic and molecular diagnostic patents under fire. Nov 6, 2015 1004
Skystar Bio-Pharmaceutical Company wins Chinese patent for T-Factor animal health supplements. Oct 28, 2015 226
Skystar Bio-Pharmaceutical Company wins Chinese patent for T-Factor animal health supplements. Oct 28, 2015 222
Pharmaceutical Patent-Antitrust: Reverse Payment Settlements and Product Hopping. Thomas, John R. Report Oct 1, 2015 8603
Kirkland's Carson helps Merus achieve win in inequitable conduct case. Aug 18, 2015 462
Kirkland's Carson helps Merus achieve win in inequitable conduct case. Aug 18, 2015 500
Patents fuel the American Dream. Jul 28, 2015 587
Japan process patent for stem cell drug stempeucel. Jun 15, 2015 179
Japan process patent for stem cell drug. Jun 15, 2015 180
Teva, FTC reach $1.2 billion settlement over patent 'pay for delay'. May 29, 2015 417
Teva, FTC reach $1.2 billion settlement over patent 'pay for delay'. May 29, 2015 454
La Jolla Pharmaceutical Company gains access to intellectual property rights for next-generation gentamicin derivatives. May 8, 2015 285
La Jolla Pharmaceutical Company gains access to intellectual property rights for next-generation gentamicin derivatives. May 8, 2015 281
PFIZER AND PROVECTUS RECEIVE PATENT ALLOWANCE. May 1, 2015 502
Patents and Regulatory Exclusivities: Issues in Pharmaceutical Innovation and Competition. Thomas, John R. Report May 1, 2015 6939
Johnson & Johnson updates US PTO's action of REMICADE. Apr 30, 2015 154
GW Pharmaceuticals receives US patent allowance for the use of cannabidivarin in treating epilepsy. Apr 27, 2015 222
GW Pharmaceuticals receives US patent allowance for the use of cannabidivarin in treating epilepsy. Apr 27, 2015 218
Pfizer and Provectus awarded US patent allowance for use of PV-10 in combination with systemic immunotherapy agents in treating cancer. Apr 20, 2015 176
Pfizer and Provectus awarded US patent allowance for use of PV-10 in combination with systemic immunotherapy agents in treating cancer. Apr 20, 2015 172
Strategic Importance of Intellectual Property (IP) in M&A 2015 Featuring Apple, ArcelorMittal, EMC, Ericsson, Google, Microsoft, Motorola, Pfizer, RIM, SONY & Rockstar Consortium. Apr 7, 2015 762
NEW BAYER FACTORY. Brief article Mar 1, 2015 168
Aurinia Pharmaceuticals receives patents for nanomicellar formulation of voclosporin. Feb 5, 2015 153
Aurinia Pharmaceuticals receives patents for nanomicellar formulation of voclosporin. Feb 5, 2015 149
Teva Pharmaceuticals and the timing of claim construction in Delaware patent infringement cases. Feb 3, 2015 876
Teva Pharmaceuticals and the timing of claim construction in Delaware patent infringement cases. Feb 3, 2015 913
Adamis Pharmaceuticals receives notice of allowance for US and Japanese patents for Taper DPI. Jan 30, 2015 156
Adamis Pharmaceuticals receives notice of allowance for US and Japanese patents for Taper DPI. Jan 30, 2015 152

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |